“…The characterization of purchases involved data collection on medicine type, dose, volume of the purchase, unit price, date, reasoning of the purchase, and type of acquisition process including a diverse range of medicines [14, 17–19, 32–34] or a therapeutic class [20, 21, 35–37], with cost per capita estimation and, in some cases, comparison with international prices or prices of specific partnerships [35].…”